Nicolet Bankshares’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.57M | Buy |
9,276
+7,563
| +442% | +$4.1M | 0.17% | 102 |
|
|
2025
Q4 | $993K | Buy |
1,713
+35
| +2% | +$19.8K | 0.16% | 96 |
|
|
2025
Q3 | $814K | Sell |
1,678
-60
| -3% | -$27.9K | 0.13% | 109 |
|
|
2025
Q2 | $705K | Buy |
1,738
+41
| +2% | +$17.1K | 0.12% | 118 |
|
|
2025
Q1 | $844K | Hold |
1,697
| – | – | 0.17% | 95 |
|
|
2024
Q4 | $883K | Sell |
1,697
-100
| -6% | -$55K | 0.21% | 96 |
|
|
2024
Q3 | $1.11M | Sell |
1,797
-234
| -12% | -$139K | 0.27% | 81 |
|
|
2024
Q2 | $1.12M | Sell |
2,031
-79
| -4% | -$45.3K | 0.28% | 75 |
|
|
2024
Q1 | $1.23M | Sell |
2,110
-286
| -12% | -$160K | 0.3% | 77 |
|
|
2023
Q4 | $1.27M | Buy |
2,396
+103
| +4% | +$49.9K | 0.34% | 67 |
|
|
2023
Q3 | $1.16M | Sell |
2,293
-44
| -2% | -$23.4K | 0.36% | 68 |
|
|
2023
Q2 | $1.22M | Sell |
2,337
-49
| -2% | -$26.4K | 0.35% | 65 |
|
|
2023
Q1 | $1.38M | Sell |
2,386
-45
| -2% | -$25.4K | 0.45% | 48 |
|
|
2022
Q4 | $1.34M | Sell |
2,431
-27
| -1% | -$14.3K | 0.46% | 46 |
|
|
2022
Q3 | $1.25M | Sell |
2,458
-35
| -1% | -$19.6K | 0.36% | 58 |
|
|
2022
Q2 | $1.35M | Buy |
2,493
+31
| +1% | +$17.1K | 0.35% | 59 |
|
|
2022
Q1 | $1.45M | Buy |
2,462
+421
| +21% | +$242K | 0.31% | 62 |
|
|
2021
Q4 | $1.36M | Sell |
2,041
-318
| -13% | -$199K | 0.3% | 61 |
|
|
2021
Q3 | $1.35M | Sell |
2,359
-27
| -1% | -$14.8K | 0.35% | 56 |
|
|
2021
Q2 | $1.2M | Sell |
2,386
-33
| -1% | -$15.6K | 0.32% | 58 |
|
|
2021
Q1 | $1.1M | Sell |
2,419
-138
| -5% | -$65.9K | 0.3% | 62 |
|
|
2020
Q4 | $1.19M | Sell |
2,557
-7
| -0.3% | -$3.28K | 0.37% | 49 |
|
|
2020
Q3 | $1.13M | Sell |
2,564
-26
| -1% | -$10.7K | 0.39% | 50 |
|
|
2020
Q2 | $938K | Sell |
2,590
-13
| -0.5% | -$4.36K | 0.35% | 59 |
|
|
2020
Q1 | $738K | Sell |
2,603
-131
| -5% | -$41.3K | 0.33% | 67 |
|
|
2019
Q4 | $888K | Sell |
2,734
-25
| -0.9% | -$7.58K | 0.33% | 65 |
|
|
2019
Q3 | $804K | Sell |
2,759
-51
| -2% | -$14.6K | 0.32% | 70 |
|
|
2019
Q2 | $825K | Sell |
2,810
-121
| -4% | -$33.3K | 0.34% | 62 |
|
|
2019
Q1 | $802K | Sell |
2,931
-50
| -2% | -$12.4K | 0.33% | 60 |
|
|
2018
Q4 | $667K | Sell |
2,981
-101
| -3% | -$23.7K | 0.32% | 66 |
|
|
2018
Q3 | $752K | Sell |
3,082
-255
| -8% | -$58.7K | 0.3% | 69 |
|
|
2018
Q2 | $691K | Hold |
3,337
| – | – | 0.29% | 72 |
|
|
2018
Q1 | $689K | Sell |
3,337
-27
| -0.8% | -$5.67K | 0.29% | 70 |
|
|
2017
Q4 | $639K | Sell |
3,364
-145
| -4% | -$27.8K | 0.27% | 76 |
|
|
2017
Q3 | $664K | Sell |
3,509
-424
| -11% | -$76.8K | 0.3% | 67 |
|
|
2017
Q2 | $686K | Hold |
3,933
| – | – | 0.32% | 63 |
|
|
2017
Q1 | $604K | Buy |
3,933
+67
| +2% | +$10.2K | 0.32% | 64 |
|
|
2016
Q4 | $545K | Sell |
3,866
-26
| -0.7% | -$3.83K | 0.3% | 67 |
|
|
2016
Q3 | $619K | Sell |
3,892
-212
| -5% | -$32.7K | 0.36% | 54 |
|
|
2016
Q2 | $606K | Sell |
4,104
-127
| -3% | -$18.7K | 0.4% | 47 |
|
|
2016
Q1 | $599K | Buy |
4,231
+84
| +2% | +$11.3K | 0.43% | 45 |
|
|
2015
Q4 | $548K | Buy |
+4,147
| New | +$553K | 0.54% | 45 |
|
Other funds holding TMO
VCM
Nicolet Bankshares's TMO Position: Q1 2026 in Review
Nicolet Bankshares increased its Thermo Fisher Scientific (TMO) stake by 442% in Q1 2026, buying an estimated $4.1M and bringing the position to 9,276 shares worth $4.57M. The position accounts for 0.17% of the portfolio, ranked #102.
Nicolet Bankshares first reported a position in TMO in Q4 2015 and has held it in 42 quarters since. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Nicolet Bankshares held 9,276 shares of Thermo Fisher Scientific worth $4.57M as of Q1 2026.
- Nicolet Bankshares bought 7,563 Thermo Fisher Scientific shares in Q1 2026, an estimated $4.1M.
- Thermo Fisher Scientific made up 0.17% of Nicolet Bankshares's portfolio in Q1 2026, its #102 holding.
- Nicolet Bankshares first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 42 quarters since.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Nicolet Bankshares's 13F filing for Q1 2026, filed 14 May 2026.